1,504 results on '"Schmidt, Ann Marie"'
Search Results
52. An Eclectic Cast of Cellular Actors Orchestrates Innate Immune Responses in the Mechanisms Driving Obesity and Metabolic Perturbation
53. Annual Report on Sex in Preclinical Studies: Arteriosclerosis, Thrombosis, and Vascular Biology Publications in 2018
54. RAGE binds preamyloid IAPP intermediates and mediates pancreatic [beta] cell proteotoxicity
55. Pharmacological antagonism of receptor for advanced glycation end products signaling promotes thermogenesis, healthful body mass and composition, and metabolism in mice
56. Abstract 445: Bone Marrow-derived Macrophage (BMDM) Extracellular Vesicles (EVs) From Diabetes Impair Angiogenesis In Ischemic Hind Limb Of Diabetic Mice
57. Abstract 226: Myeloid Deletion Of Rage Induces Insulin Resistance By Impairing Macrophage And Adipocyte Crosstalk In Obese Adipose Tissues
58. A randomized clinical trial comparing low-fat versus precision nutrition-based diets for weight loss: impact on glycemic variability and HbA1c
59. Abstract 638: Ligands Of The Receptor For Advanced Glycation End Products (Rage) Induce Trained Immunity In Mouse Bone Marrow-derived Macrophages (Bmdms)
60. Recipients of the 2023 Early Career Investigator Awards
61. Supplementary Table 1 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
62. Supplementary Figure 2 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
63. Supplementary Figure 1 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
64. Data from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
65. Supplementary Methods, Legends for Table 1, Figures 1-3 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
66. Supplementary Figure 3 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
67. Amyloid-β Peptide-Receptor for Advanced Glycation Endproduct Interaction Elicits Neuronal Expression of Macrophage-Colony Stimulating Factor: A Proinflammatory Pathway in Alzheimer Disease
68. Metabolism, Obesity, and Diabetes Mellitus: Recent Studies in Cellular and Animal Models and Human Subjects Highlight Mechanisms and Consequences of Metabolic Dysfunction
69. Diabetes Mellitus and Cardiovascular Disease: Emerging Therapeutic Approaches
70. PET imaging study of brown adipose tissue (BAT) activity in mice devoid of receptor for advanced glycation end products (RAGE)
71. Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association's Strategically Focused Research Network
72. Soluble RAGEs — Prospects for treating & tracking metabolic and inflammatory disease
73. The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease
74. Effect of a Personalized Diet to Reduce Postprandial Glycemic Response vs a Low-fat Diet on Weight Loss in Adults With Abnormal Glucose Metabolism and Obesity
75. Advanced Glycation End Products, RAGE, and Aging
76. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation
77. Unlocking the biology of RAGE in diabetic microvascular complications
78. Reporting Sex and Sex Differences in Preclinical Studies
79. RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity
80. Highlighting Diabetes Mellitus: The Epidemic Continues
81. Cardiometabolic disease: linking pathogenic mechanisms to therapeutic opportunities.
82. AGE-RAGE Axis in the Aging and Diabetic Heart
83. Types of tobacco consumption and the oral microbiome in the United Arab Emirates Healthy Future (UAEHFS) Pilot Study
84. Glycation : Receptor for Advanced Glycation Endproducts and Diabetic Nephropathy
85. The receptor for advanced glycation end products and its ligands’ expression in OVE26 diabetic sciatic nerve during the development of length‐dependent neuropathy
86. Aldose reductase promotes diet‐induced obesity via induction of senescence in subcutaneous adipose tissue
87. ATVB : Entering the Next Era
88. Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) – Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease
89. The association between mediators of the receptor for advanced glycation end product (RAGE) axis and immune checkpoint inhibitor (ICI)–induced colitis in patients with melanoma.
90. Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis
91. Mechanisms of islet amyloidosis toxicity in type 2 diabetes
92. Chronic neuronal perturbation mediated by RAGE, a receptor for β-sheet fibrils and S100/calgranulins
93. Endothelial Cell Injury
94. The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes
95. RAGE mediates vascular injury and inflammation after global cerebral ischemia
96. The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications
97. Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigs
98. Additional file 1 of Association between depression, happiness, and sleep duration: data from the UAE healthy future pilot study
99. Receptor for Advanced Glycation End Products Facilitates Host Defense during Escherichia coli-Induced Abdominal Sepsis in Mice
100. Calreticulin and Thrombosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.